Corporate Responsibility Worldwide
We take responsibility and support programs that help to improve access to healthcare and enhance the quality of life worldwide.
We strive to improve the health and well-being of all people around the world
We have set ourselves the goal of reaching at least 75% of countries worldwide with our products every year.
MSD FOR MOTHERS
Every two minutes, a woman dies from complications during pregnancy or childbirth – we want to change that.
With the MSD for Mothers project, we are working on a sustainable improvement in the healthcare system for expectant mothers. We focus on improving access to quality care, treatment and prevention for pregnant and birthing women. Working with our partners, we can help make pregnancy and childbirth a safe, healthy and positive experience for women.
IVERMECTIN DONATION PROGRAM
More than 30 years ago, MSD founded the Ivermectin Donation Program (MDP). Since 1987, we have been committed to donating ivermectin for the treatment of onchocerciasis – also known as river blindness – to those who need it for as long as they need it. In addition, we have expanded our donation program to include the treatment of lymphatic filariasis (LF). MSD will provide these drugs free of charge until both diseases have been eliminated worldwide. As the WHO has already confirmed, we have already been able to defeat river blindness in Colombia, Ecuador, Guatemala and Mexico.
ELEFANTIASIS
Following the success of the Ivermectin program, MSD decided to expand the program to lymphatic filariasis, commonly known as elephantiasis, in 1998. Since the start of the donation program, more than 3.4 billion treatments have been carried out in 29 countries in Equatorial Africa, Central and South America and Yemen, reaching more than 300 million people in the affected areas every year.
FELLOWSHIP PROGRAM
We want to find smart and sustainable ways to improve access to healthcare – especially in areas with limited infrastructure and resources. To this end, we work with selected non-profit organizations. Each year, MSD enables up to 30 Group employees to support organizations with limited resources as part of a three-month fellowship.
Together with our partners such as governments, patient organizations, multilateral organizations, and partners from the healthcare and private sectors, we aim to strengthen the capacity and reach of non-profit organizations to solve some of the world’s biggest healthcare challenges.
EBOLA
Since 1976, when the Ebola virus was first discovered, the number of outbreaks has been steadily increasing and poses a global challenge. MSD has therefore made it its mission to fight this deadly disease with the help of numerous organizations and volunteers.
In 2019, the first vaccine against Ebola developed by MSD together with the European Medicines Agency and the WHO was approved. To date, 253,000 doses of the vaccine have already been shipped and more than 238,000 people have been vaccinated.
PROTECTION AGAINST COUNTERFEIT MEDICINES
We take measures worldwide to combat counterfeit medicines and support criminal and civil sanctions for counterfeiters.
Counterfeit medicines pose a threat to public health worldwide. Many counterfeit medicines contain the wrong dosage of the active ingredient or no active ingredient at all. In some cases, they also contain substances that are harmful to health.
AT-NON-02839, created February 2025